|
Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 96 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Liver Cancer clinical trial scenario. This report pr.....
Introduction GlobalData's clinical trial report, “Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Liver Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Metastatic Liver Cancer 7 Report Guidance 7 Clinical Trials by Region 8 Clinical Trials by Country 9 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11 Top Five Countries Contributing to Clinical Trials in Europe 12 Top Countries Contributing to Clinical Trials in North America 13 Top Countries Contributing to Clinical Trials in Middle East and Africa 14 Top Countries Contributing to Clinical Trials in Central and South America 15 Clinical Trials by BRIC Nations 16 Clinical Trials by G7 Nations 17 Clinical Trials in G7 Nations by Trial Status 18 Clinical Trials by E7 Nations 19 Clinical Trials in E7 Nations by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Unaccomplished Trials of Metastatic Liver Cancer 24 Subjects Recruited Over a Period of Time 27 Prominent Sponsors 28 Top Companies Participating in Metastatic Liver Cancer Therapeutics Clinical Trials 30 Prominent Drug Comparison 32 Clinical Trial Profiles 33 Clinical Trial Overview of Top Companies 33 AstraZeneca PLC 33 Clinical Trial Overview of AstraZeneca PLC 33 F. Hoffmann-La Roche Ltd. 34 Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 34 Light Sciences Oncology, Inc. 35 Clinical Trial Overview of Light Sciences Oncology, Inc. 35 Sirtex Medical Limited 36 Clinical Trial Overview of Sirtex Medical Limited 36 NS Pharma, Inc. 37 Clinical Trial Overview of NS Pharma, Inc. 37 Gradalis Inc. 38 Clinical Trial Overview of Gradalis Inc. 38 Matrix Pharma (Canada) Inc. 39 Clinical Trial Overview of Matrix Pharma (Canada) Inc. 39 Micromet AG 40 Clinical Trial Overview of Micromet AG 40 AVEO Pharmaceuticals, Inc. 41 Clinical Trial Overview of AVEO Pharmaceuticals, Inc. 41 Matrix Pharmaceutical Research 42 Clinical Trial Overview of Matrix Pharmaceutical Research 42 Provectus Pharmaceuticals, Inc. 43 Clinical Trial Overview of Provectus Pharmaceuticals, Inc. 43 Bayer AG 44 Clinical Trial Overview of Bayer AG 44 Pfizer Inc. 45 Clinical Trial Overview of Pfizer Inc. 45 Merck & Co., Inc. 46 Clinical Trial Overview of Merck & Co., Inc. 46 Biogen Idec Inc. 47 Clinical Trial Overview of Biogen Idec Inc. 47 Celsion Corporation 48 Clinical Trial Overview of Celsion Corporation 48 Boston Scientific Corporation 49 Clinical Trial Overview of Boston Scientific Corporation 49 Clinical Trial Overview of Top Universities / Institutes / Hospitals 50 The University of Texas M. D. Anderson Cancer Center 50 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 50 University Health Network 51 Clinical Trial Overview of University Health Network 51 Radboud University 52 Clinical Trial Overview of Radboud University 52 University of Pittsburgh 53 Clinical Trial Overview of University of Pittsburgh 53 Massachusetts General Hospital 54 Clinical Trial Overview of Massachusetts General Hospital 54 Kyoto University 55 Clinical Trial Overview of Kyoto University 55 University of California, San Diego 56 Clinical Trial Overview of University of California, San Diego 56 University of Michigan Comprehensive Cancer Center 57 Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 57 Samsung Medical Center 58 Clinical Trial Overview of Samsung Medical Center 58 University of Heidelberg 59 Clinical Trial Overview of University of Heidelberg 59 Aarhus University 60 Clinical Trial Overview of Aarhus University 60 European Organization for Research and Treatment of Cancer 61 Clinical Trial Overview of European Organization for Research and Treatment of Cancer 61 Kansai Medical University 62 Clinical Trial Overview of Kansai Medical University 62 Cancer Prevention Institute of California 63 Clinical Trial Overview of Cancer Prevention Institute of California 63 Sidney Kimmel Comprehensive Cancer Center 64 Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 64 Dana-Farber Cancer Institute 65 Clinical Trial Overview of Dana-Farber Cancer Institute 65 Roswell Park Cancer Institute 66 Clinical Trial Overview of Roswell Park Cancer Institute 66 Odense University Hospital 67 Clinical Trial Overview of Odense University Hospital 67 Royal Marsden Cancer Campaign 68 Clinical Trial Overview of Royal Marsden Cancer Campaign 68 University of Michigan 69 Clinical Trial Overview of University of Michigan 69 Five Key Clinical Profiles 70 Appendix 93 Abbreviations 93 Definitions 93 Research Methodology 94 Secondary Research 94 About GlobalData 95 Contact Us 95 Disclaimer 95 Source 96 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8 Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Metastatic Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11 Metastatic Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12 Metastatic Liver Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 13 Metastatic Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14 Metastatic Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15 Metastatic Liver Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 16 Metastatic Liver Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 17 Metastatic Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Metastatic Liver Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 19 Metastatic Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21 Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22 Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Metastatic Liver Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24 Metastatic Liver Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25 Metastatic Liver Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26 Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27 Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29 Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31 Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 33 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 34 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Light Sciences Oncology, Inc., 2012* 35 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sirtex Medical Limited, 2012* 36 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NS Pharma, Inc., 2012* 37 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gradalis Inc., 2012* 38 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Matrix Pharma (Canada) Inc., 2012* 39 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Micromet AG, 2012* 40 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AVEO Pharmaceuticals, Inc., 2012* 41 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Matrix Pharmaceutical Research, 2012* 42 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Provectus Pharmaceuticals, Inc., 2012* 43 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 44 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 45 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 46 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2012* 47 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celsion Corporation, 2012* 48 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific Corporation, 2012* 49 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 50 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012* 51 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012* 52 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 53 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 54 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012* 55 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2012* 56 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012* 57 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012* 58 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2012* 59 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012* 60 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012* 61 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kansai Medical University, 2012* 62 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Prevention Institute of California, 2012* 63 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012* 64 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 65 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 66 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2012* 67 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Marsden Cancer Campaign, 2012* 68 Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2012* 69 List of Figures Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8 Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Metastatic Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11 Metastatic Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12 Metastatic Liver Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13 Metastatic Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 14 Metastatic Liver Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16 Metastatic Liver Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 17 Metastatic Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Metastatic Liver Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 19 Metastatic Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21 Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22 Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27 Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28 Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30 Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32 GlobalData Methodology 94 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
